Record Abstract Submission for BOPA Annual Conference 2026

BOPA is thrilled to announce that we have received an incredible number of 235 abstracts for our annual conference 2026. The record number of abstract is testament to our continued growth and support to practice research in cancer pharmacy. BOPA is committed to support the cancer pharmacy workforce in embedding research and innovation within their practice to develop evidence to guide best practice, in one of our vision pillars.

Abstract marking is now underway and authors of accepted abstract can expect to be informed by Friday 14th August.

Latest News

By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article
By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article
By BOPA Committee on 12th August 2026

The British Colorectal Oncology Group (BCOG) Annual Conference 2026 – Register NOW

The British Colorectal Oncology Group warmly invites you to its inaugural annual conference at the Queen’s Hotel, Leeds Find the conference agenda here – BCOG-Annual-Conference-Programme-2026.pdf Register NOW – British Colorectal…

Read article
By BOPA Executive Committee on 10th August 2026

Highlights of CAPhO Conference 2026 Webinar

Participants are invited to participate in the Highlights of CAPhO Conference 2026 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO). Taking place on Wednesday, August 19, 2026 at 08:00 PT,…

Read article